• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工智能医学软件使用的监管方面

Regulatory Aspects of the Use of Artificial Intelligence Medical Software.

作者信息

Zanca Federica, Brusasco Caterina, Pesapane Filippo, Kwade Zuzanna, Beckers Ruth, Avanzo Michele

机构信息

Palindromo Consulting, Leuven, Belgium.

MedDevConsult, Bossiere, Belgium; R&D Department, Ion Beam Applications, Louvain la Neuve, Belgium.

出版信息

Semin Radiat Oncol. 2022 Oct;32(4):432-441. doi: 10.1016/j.semradonc.2022.06.012.

DOI:10.1016/j.semradonc.2022.06.012
PMID:36202445
Abstract

The rapidly evolving scenario of Artificial intelligence (AI) in medicine comes with new regulatory challenges, including certification, ownership, and control of data sharing, privacy protection, and accountability. The Medical Physicists (MPs) are traditionally responsible for ensuring the safety and quality of technology implementation in diagnostic and therapeutic settings. As such, they are also expected to contribute to the introduction of AI medical devices in routine clinical practice. Specifically, the MPs will play a stakeholder role for AI tools procurement, acceptance testing, commissioning, and quality assurance to confirm the claimed performances in relation to the medical device's intended use. Moreover, MPs who act as co-creators of such AI tools, will play a pivotal role in product requirements definition, data collection and annotation, clinical evaluation, support for regulatory pathways and marketing through scientific congresses and scientific publications. As AI software differs from the traditional (hardware) medical device that the MP is used to introduce in clinical settings, there is a need to acquire new competencies in the field of AI and its regulatory aspects. The purpose of this paper is to provide MPs with practical guidelines on regulatory aspects of AI medical devices, in the European and in the US landscape.

摘要

人工智能(AI)在医学领域迅速发展的形势带来了新的监管挑战,包括认证、所有权、数据共享的控制、隐私保护和问责制。传统上,医学物理师(MPs)负责确保诊断和治疗环境中技术应用的安全性和质量。因此,人们也期望他们为将人工智能医疗设备引入常规临床实践做出贡献。具体而言,医学物理师将在人工智能工具的采购、验收测试、调试和质量保证中扮演利益相关者的角色,以确认与医疗设备预期用途相关的宣称性能。此外,作为此类人工智能工具共同创造者的医学物理师,将在产品需求定义、数据收集和标注、临床评估、支持监管途径以及通过科学大会和科学出版物进行营销方面发挥关键作用。由于人工智能软件不同于医学物理师习惯在临床环境中引入的传统(硬件)医疗设备,因此需要在人工智能领域及其监管方面获得新的能力。本文的目的是为医学物理师提供关于欧洲和美国环境下人工智能医疗设备监管方面的实用指南。

相似文献

1
Regulatory Aspects of the Use of Artificial Intelligence Medical Software.人工智能医学软件使用的监管方面
Semin Radiat Oncol. 2022 Oct;32(4):432-441. doi: 10.1016/j.semradonc.2022.06.012.
2
Methodology for Conducting Post-Marketing Surveillance of Software as a Medical Device Based on Artificial Intelligence Technologies.基于人工智能技术的医疗器械软件上市后监测方法学。
Sovrem Tekhnologii Med. 2022;14(5):15-23. doi: 10.17691/stm2022.14.5.02. Epub 2022 Sep 29.
3
ARTIFICIAL INTELLIGENCE IN MEDICAL PRACTICE: REGULATIVE ISSUES AND PERSPECTIVES.人工智能在医学实践中的应用:监管问题与展望。
Wiad Lek. 2020;73(12 cz 2):2722-2727.
4
Translating the regulatory landscape of medical devices to create fit-for-purpose artificial intelligence (AI) cytometry solutions.将医疗器械监管格局转化为适合目的的人工智能(AI)细胞检测解决方案。
Cytometry B Clin Cytom. 2024 Jul;106(4):294-307. doi: 10.1002/cyto.b.22167. Epub 2024 Feb 23.
5
Toward a responsible future: recommendations for AI-enabled clinical decision support.迈向负责任的未来:人工智能支持的临床决策支持的建议。
J Am Med Inform Assoc. 2024 Nov 1;31(11):2730-2739. doi: 10.1093/jamia/ocae209.
6
The EU medical device regulation: Implications for artificial intelligence-based medical device software in medical physics.欧盟医疗器械法规:对医疗物理学中基于人工智能的医疗器械软件的影响。
Phys Med. 2021 Mar;83:1-8. doi: 10.1016/j.ejmp.2021.02.011. Epub 2021 Feb 28.
7
Artificial intelligence in medical device software and high-risk medical devices - a review of definitions, expert recommendations and regulatory initiatives.人工智能在医疗器械软件和高风险医疗器械中的应用——定义、专家建议和监管举措的综述。
Expert Rev Med Devices. 2023 Jun;20(6):467-491. doi: 10.1080/17434440.2023.2184685. Epub 2023 May 8.
8
AI in imaging: the regulatory landscape.人工智能在影像学中的应用:监管现状。
Br J Radiol. 2024 Feb 28;97(1155):483-491. doi: 10.1093/bjr/tqae002.
9
A "Do No Harm" Novel Safety Checklist and Research Approach to Determine Whether to Launch an Artificial Intelligence-Based Medical Technology: Introducing the Biological-Psychological, Economic, and Social (BPES) Framework.“不伤害”新型安全检查表和研究方法,以确定是否推出基于人工智能的医疗技术:引入生物-心理-经济-社会(BPES)框架。
J Med Internet Res. 2023 Apr 5;25:e43386. doi: 10.2196/43386.
10
Artificial intelligence in radiography: Where are we now and what does the future hold?人工智能在放射学中的应用:我们现在在哪里,未来会怎样?
Radiography (Lond). 2021 Oct;27 Suppl 1:S58-S62. doi: 10.1016/j.radi.2021.07.015. Epub 2021 Aug 8.

引用本文的文献

1
The Potential of Artificial Intelligence in Pharmaceutical Innovation: From Drug Discovery to Clinical Trials.人工智能在药物创新中的潜力:从药物发现到临床试验
Pharmaceuticals (Basel). 2025 May 25;18(6):788. doi: 10.3390/ph18060788.
2
Automatic quantification of left atrium volume for cardiac rhythm analysis leveraging 3D residual UNet for time-varying segmentation of ECG-gated CT.利用3D残差UNet对心电图门控CT进行时变分割,自动定量左心房容积以进行心律分析。
Comput Struct Biotechnol J. 2025 May 13;28:175-189. doi: 10.1016/j.csbj.2025.04.039. eCollection 2025.
3
Applying and validating a quality management system for in-house developed medical software.
应用并验证针对内部开发的医疗软件的质量管理体系。
Front Digit Health. 2025 Apr 1;7:1461107. doi: 10.3389/fdgth.2025.1461107. eCollection 2025.
4
Models for the marrow: A comprehensive review of AI-based cell classification methods and malignancy detection in bone marrow aspirate smears.骨髓模型:基于人工智能的骨髓涂片细胞分类方法与恶性肿瘤检测的全面综述
Hemasphere. 2024 Dec 3;8(12):e70048. doi: 10.1002/hem3.70048. eCollection 2024 Dec.
5
The Evolution of Artificial Intelligence in Medical Imaging: From Computer Science to Machine and Deep Learning.医学成像中人工智能的发展:从计算机科学到机器学习与深度学习
Cancers (Basel). 2024 Nov 1;16(21):3702. doi: 10.3390/cancers16213702.
6
Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion.人工智能对炎症性肠病患者预后、共同决策和精准医学的影响:观点和专家意见。
Ann Med. 2023;55(2):2300670. doi: 10.1080/07853890.2023.2300670. Epub 2024 Jan 1.
7
Clinical Use of a Commercial Artificial Intelligence-Based Software for Autocontouring in Radiation Therapy: Geometric Performance and Dosimetric Impact.一种基于人工智能的商业软件在放射治疗自动轮廓勾画中的临床应用:几何性能和剂量学影响
Cancers (Basel). 2023 Dec 7;15(24):5735. doi: 10.3390/cancers15245735.
8
Call for the responsible artificial intelligence in the healthcare.呼吁在医疗保健中使用负责任的人工智能。
BMJ Health Care Inform. 2023 Dec 21;30(1):e100920. doi: 10.1136/bmjhci-2023-100920.
9
ChatGPT fails the test of evidence-based medicine.ChatGPT未通过循证医学的检验。
Eur Heart J Digit Health. 2023 Jul 13;4(5):366-367. doi: 10.1093/ehjdh/ztad043. eCollection 2023 Oct.
10
Ethical Considerations of Using ChatGPT in Health Care.使用 ChatGPT 在医疗保健中的伦理考虑。
J Med Internet Res. 2023 Aug 11;25:e48009. doi: 10.2196/48009.